Korea’s new Covid-19 cases remained above 80,000 for the second straight day. However, despite the rise of the BN.1 mutations, officials said its spread would not be as quick as the BA.5 variant.Even amid the resurge of new virus cases, the Korea Disease Control and Prevention Agency (KDCA) said it
The Health Insurance Review and Assessment Service (HIRA) said it would operate a system to manage “super-expensive” drugs, such as Kymriah and Zolgensma, including their course of medication.The state-run agency said Wednesday that it would run the system to “manage expensive drugs” to enhance the
GC Wellbeing has signed a technology transfer and joint development agreement for GCWB204, its cancer cachexia treatment candidate, with MThera Pharma.In a European phase 2a clinical trial last year, GC Wellbeing confirmed the potential of GCWB204 as a treatment for cancer cachexia in multiple evalu
As the calls grow for fostering a professional workforce in the biopharmaceutical industry, Korea’s next-generation flagship sector, experts call for integrated management led by the government.In an article published in the industrial brief of the Korea Health Industry Development Institute (KHIDI)
Lilly Korea's CDK4/6 inhibitor Verzenio (ingredient: abemaciclib) will be an alternative treatment for the complete recovery of early breast cancer patients with a high risk of recurrence, the company said Wednesday.In November, Lilly Korea obtained expanded indication approval from the Ministry of
The nation should check its healthcare system before it gets too late to effectively prepare for repeated disastrous infectious diseases, like new influenza, MERS, and Covid-19, experts pointed out Tuesday.At a joint forum co-hosted by three organizations, including the Korean Federation of Science
SK Biopharmaceuticals presented the company’s roadmap and vision for its digital healthcare business ahead of CES 2023 at a media briefing in Seoul on Wednesday.For instance, SK Biopharma’s “Project Zero” aims to become a total healthcare solution provider by developing wearable devices converged wi
Myongji Hospital received a commendation from Gyeonggi Province for revitalizing the dementia management system in the province surrounding the capital Seoul.According to the hospital, Myongji became the first private hospital to launch a public healthcare project group in 2013 and established the "
Helixmith said Wednesday that it has developed a new freeze-drying formulation for its gene therapy, Engensis (VM202), further improving advantages in its manufacturing process and obtaining a patent in the U.S.The new formulation forms a superior cake quality and increases the stability of Engensis
As experts expected, Korea's new Covid-19 cases are on the resurge in winter, reaching a three-month high on Tuesday.The resurgence came when the quarantine authorities carefully sounded out the possibility of lifting indoor mask mandates, as eagerly anticipated by the public.According to the Korea
Korea is home to a rapidly growing bioindustry; nothing showed this better than the Bioindustry Networking event hosted by KoreaBio Tuesday, which drew keen attention from the Swiss, U.S., U.K., Canadian, and Vietnamese embassies in Korea.The who’s who of the local bio industry attended the event as
Bionote said Monday that it confirmed the final public offering price at 9,000 won ($6.90) due to demand forecast from institutional investors from last Thursday to Friday.While the company initially planned to offer 13 million depository receipts at the offering price range of 18,000 won to 22,000
The government will introduce a system to evaluate and certify institutions that attract foreign patients.The Ministry of Health and Welfare said Tuesday that an “amendment to the implementation decree of the act on supporting overseas medical advance and attracting foreign patients” was approved at
As China abandons its “zero-Covid” policy, the Korean pharmaceutical companies are guessing whether it would work as a crisis or an opportunity.The Chinese government issued quarantine guidelines that allowed people infected with Covid-19 to self-isolate and significantly eased the polymerase chain
Celltrion said Tuesday it has proved once again the safety and effectiveness of Truxima(ingredient: rituximab), a hematologic malignancy treatment, through the internal post-marketing surveillance(PMS) at the American Society of Hematology (ASH) 2022.The clinical trial is the data on 677 safety eval
A heated debate is going on whether to view the three CDK4/6 inhibitors – Ibrance, Kisqali, and Verzenio -- in treating breast cancer as the same drug group or as individual drug groups.These CKD (cyclin-dependent kinase)4/6 inhibitors are said to have changed the treatment paradigm of HR+ (hormone
SillaJen will increase corporate value by increasing the company’s capabilities to research and develop new drugs, its top manager said.SillaJen CEO Kim Jae-kyung remarked at a news conference Tuesday to present the company’s current R&D status and plans after resuming its stock trading in the tech-
LG Chem said Tuesday that it confirmed the safety and efficacy of Zemidapa as a dual add-on therapy for type 2 diabetes patients who do not respond well to metformin standard diabetes treatments in phase 3 clinical trial.Zemidapa combines Zemiglo (ingredient: gemigliptin), a type 2 diabetes treatmen
An annual average of 11.2 billion won ($8.36 million) flows out of the state health insurance fund due to short-term foreign sojourners of less than six months registered as beneficiaries.Rep. Lee Jong-seong of the ruling People Power Party said so on Monday, based on his analysis of the National He
Korea added 25,667 new Covid-19 infections, including 63 cases from abroad, bringing the total caseload to 27,754,149, according to the Korea Disease Control and Prevention Agency (KDCA). The figure is the highest caseload for a Monday since Sep. 12, when the country reported 36,917 cases.The nation